🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will treat patients with advanced NSCLC who have already receive...
Status
Completed
Location
Research Site
Start Date
2013-03-04
Trial ID
NCT01802632
Treatments Being Tested
This is an open-label, multi-center, randomized, phase III study. It is aim...
Status
Active Not Recruiting
Location
Guangdong Lung cancer institute
Start Date
2022-06-20
Trial ID
NCT04841811
Treatments Being Tested
This phase I trial studies the side effects and best dose of sapanisertib w...
Status
Active Not Recruiting
Location
Smilow Cancer Center/Yale-New Haven Hospital
Start Date
2017-03-23
Trial ID
NCT02503722
Treatments Being Tested
Gliomas are a heterogeneous group of tumors arising from glial cells in the...
Status
Recruiting
Location
Biogenea Pharmaceuticals Ltd
Start Date
2025-07-01
Trial ID
NCT07077616
This is a prospective, multicenter, randomized controlled, phase II study. ...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07621497
The main purpose of this study is to explore the value of multimodal imagin...
Status
Not Yet Recruiting
Location
Wuhan Union Hospital
Start Date
2025-12-25
Trial ID
NCT07287904
Treatments Being Tested
A national, prospective, multi-center, open-label, multi-cohort study compr...
Status
Recruiting
Location
Soonchunhyang University Hospital Bucheon
Start Date
2022-09-28
Trial ID
NCT05525858
This is an open-label, non-randomized, multicenter phase Ib/II study, which...
Status
Completed
Location
National Cheng Kung University Hospital
Start Date
2014-09
Trial ID
NCT02025114
Treatments Being Tested
The primary objective is to describe the quality of life of long-term survi...
Status
Completed
Location
Research Site
Start Date
2009-08
Trial ID
NCT01000740
Treatments Being Tested
Patients will receive AZD9291 at a dose of 80 mg once daily. Intracranial r...
Status
Unknown
Location
Shaare Zedek
Start Date
2016-05
Trial ID
NCT02736513
Treatments Being Tested